Zepbound
FDA-approved GLP-1 medications and their generic active ingredients.
Definition
Once-weekly injectable tirzepatide FDA-approved 2023 for chronic weight management. Dual GLP-1/GIP receptor agonist; produced ~21% body weight reduction at 15 mg in SURMOUNT-1.
Tirzepatide vs semaglutide head-to-head →
Definition curated by Weight Loss Rankings — sourced from FDA labels and peer-reviewed PubMed literature, never AI-generated summaries.
Related terms in Drugs and brands
Looking for more depth?
- Tirzepatide vs semaglutide head-to-head
- Browse the full GLP-1 glossary (51 terms across 8 categories)
- Research articles — primary-source deep dives
- Tools and calculators
- Compare GLP-1 telehealth providers